Cilostazol for Parkinson's disease with dyskinesia
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether the drug cilostazol can help people with Parkinson's disease who have involuntary movements (dyskinesia) caused by their levodopa treatment. You may join if you have had Parkinson's for at least 5 years, take stable doses of levodopa/carbidopa, and have dyskinesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older)
- You have Parkinson's disease diagnosed by a specialist using standard criteria
- You have had Parkinson's for at least 5 years
- You have been on a steady dose of levodopa/carbidopa for the past 6 months
- You have involuntary movements (dyskinesia) caused by your Parkinson's medication
- You are not on blood thinners (like warfarin) or other antiplatelet drugs, and do not have heart failure or serious liver/kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the blood pressure drug terazosin can help slow down Parkinson's disease. It is for people recently diagnosed (within 3 years) who are not yet on many Parkinson's medications.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
This trial tests whether cilostazol, a medication that helps keep blood flowing, can prevent another stroke and slow down disease progression in people who have had a recent stroke caused by small vessel disease. It aims to stop the brain damage from getting worse.
This trial tests if the drug cilostazol can prevent another stroke in people who have already had one. It is designed for patients in Africa and compares adding cilostazol to standard aspirin or clopidogrel therapy.
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
This trial tests a drug called cilostazol to see if it can help prevent a second stroke or mini-stroke. You may be a candidate if you have had a stroke or mini-stroke in the past 6 months and are already taking one blood thinner (aspirin or clopidogrel), but not both.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.